Takeda Pharmaceutical Company Limited held the grand opening of Takeda Global Headquarters in Tokyo, Japan. The building, completed in March 2018, will serve as Takeda’s head office for its operations worldwide.
At the grand opening, Creative Director Kashiwa Sato, Takeda’s President and CEO Christophe Weber, and Takeda’s Head of Corporate Strategy and the CEO Office, Yasuhiro Fukutomi, who managed the project, took to the stage to introduce the objectives and significance of the project as the company accelerates its transformation.
“Takeda Global Headquarters symbolizes the passing on to the next generation of Takeda’s unwavering identity and values as a company, with its roots in Japan, yet reaching patients worldwide,” said Takeda President and CEO, Christophe Weber. “Moreover, it will provide a base for our diverse workforce of around 30,000 employees across the globe where they can connect, collaborate, learn and share, in an environment designed to offer comfort and inspiration. From here in Nihonbashi, Tokyo, we will pursue our mission of contributing to better health and a brighter future for people worldwide, while nurturing our relationship with the local community.”
Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. The company conducts R&D both internally and with partners to stay at the leading edge of innovation. Innovative products, especially in oncology and gastroenterology, as well as Takeda’s presence in emerging markets, are currently fueling the growth of Takeda.